Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2013; 19(16): 2543-2549
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2543
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2543
Table 1 Baseline characteristics of the patients n (%)
Characteristics | Total (n = 412) | Severe hepatitis (n = 92) | Non-severe hepatitis (n = 320) | P value | Prolonged cholestasis(n = 21) | Non-prolonged cholestasis (n = 391) | P value |
Age1 (yr) | 34.4 ± 11.4 | 36.5 ± 11.5 | 33.8 ± 11.4 | 0.035 | 42.6 ± 15.0 | 34.0 ± 11.1 | 0.013 |
Gender, male | 237 (57.5) | 62 (67.4) | 175 (54.7) | 0.032 | 11 (52.4) | 226 (57.8) | 0.655 |
Etiology | |||||||
Hepatitis A | 319 (77.4) | 67 (72.8) | 252 (78.8) | 8 (38.1) | 311 (79.5) | ||
Toxic | 44 (10.7) | 17 (18.5) | 27 (8.4) | 10 (47.6) | 34 (8.7) | ||
Unknown | 25 (6.1) | 1 (1.1) | 24 (7.5) | 0 (0) | 25 (6.4) | ||
Hepatitis B | 16 (3.9) | 4 (4.3) | 12 (3.8) | 2 (9.5) | 14 (3.6) | ||
Alcohol | 4 (1.0) | 1 (1.1) | 3 (0.9) | 0 (0) | 4 (1.0) | ||
Hepatitis C | 2 (0.5) | 1 (1.1) | 1 (0.3) | 1 (4.8) | 1 (0.3) | ||
Autoimmune | 2 (0.5) | 1 (1.1) | 1 (0.3) | 0 (0) | 2 (0.5) | ||
Etiology, toxic | 44 (10.7) | 17 (18.5) | 27 (8.4) | 0.001 | 10 (47.6) | 34 (8.7) | < 0.001 |
ALT1 (IU/L) | 2053 ± 1759 | 2145 ± 2207 | 2027 ± 1611 | 0.392 | 998 ± 1090 | 2110 ± 1772 | 0.001 |
ALP1 (IU/mL) | 155 ± 75 | 152 ± 72 | 156 ± 76 | 0.983 | 153 ± 110 | 156 ± 73 | 0.265 |
Bilirubin1 (mg/dL) | 5.6 ± 4.9 | 11.2 ± 6.7 | 3.9 ± 2.6 | < 0.001 | 18.6 ± 6.9 | 4.9 ± 3.7 | < 0.001 |
Albumin1 (g/dL) | 3.9 ± 0.4 | 3.8 ± 0.4 | 4.0 ± 0.4 | < 0.001 | 3.8 ± 0.4 | 3.9 ± 0.4 | 0.174 |
PT1 (%) | 81.0 ± 18.0 | 75.2 ± 22.7 | 83.7 ± 16.6 | 0.003 | 84.6 ± 15.0 | 81.7 ± 18.6 | 0.721 |
GWT1, mm | 5.2 ± 5.5 | 7.2 ± 6.0 | 5.5 ± 5.3 | 0.009 | 9.6 ± 6.7 | 5.7 ± 5.4 | 0.003 |
> 3 | 233 (56.5) | 70 (70.7) | 168 (51.7) | 0.004 | 17 (81.0) | 216 (55.2) | 0.025 |
> 7 | 142 (34.5) | 36 (39.1) | 106 (33.1) | 0.040 | 11 (52.4) | 131 (33.5) | 0.005 |
Arterial heterogeneity (+) | 294 (80.1) | 68 (73.9) | 226 (70.6) | 0.755 | 15 (71.5) | 279 (71.3) | 1.000 |
Periportal tracking (+) | 348 (84.7) | 78 (84.8) | 270 (84.4) | 0.869 | 18 (85.7) | 330 (84.4) | 1.000 |
LN number1 | 4.8 ± 3.0 | 5.1 ± 3.3 | 4.8 ± 2.9 | 0.581 | 5.3 ± 3.7 | 4.8 ± 3.0 | 0.701 |
LN size1 (cm) | 0.97 ± 0.26 | 0.99 ± 0.28 | 0.96 ± 0.26 | 0.465 | 0.97 ± 0.30 | 0.97 ± 0.26 | 0.743 |
≥ 0.8 | 346 (84.5) | 79 (85.9) | 267 (83.4) | 0.632 | 17 (81.0) | 329 (84.1) | 0.759 |
> 1 | 162 (39.3) | 42 (45.7) | 120 (37.5) | 0.183 | 10 (47.6) | 152 (38.9) | 0.494 |
Ascites (+) | 56 (13.6) | 17 (18.5) | 39 (12.2) | 0.123 | 7 (33.3) | 49 (12.5) | 0.015 |
Spleen size1 (cm) | 10.9 ± 1.6 | 11.04 ± 1.68 | 10.84 ± 1.60 | 0.419 | 10.44 ± 1.7 | 10.91 ± 1.6 | 0.094 |
≥ 12 | 95 (23.1) | 24 (26.1) | 71 (22.2) | 0.483 | 3 (14.3) | 92 (23.5) | 0.431 |
Table 2 Relationship between computed tomography findings and liver chemistry (mean ± SD)
GWT | LN maximum size | LN number | Spleen size | Arterial heterogeneity | Periportal tracking | Ascites | |||||||
Absence (n = 73) | Presence (n = 294) | P value | Absence (n = 63) | Presence (n = 348) | P value | Absence (n = 356) | Presence (n = 56) | P value | |||||
ALT(IU/L) | 0.234 (< 0.001) | 0.164 (0.001) | -0.013 (0.798) | 0.119 (0.015) | 1504 ± 1478 | 2216 ± 1794 | < 0.001 | 1994 ± 2139 | 2064 ± 1688 | 0.074 | 1981 ± 1769 | 2509 ± 1641 | 0.005 |
ALP (IU/mL) | 0.180 (< 0.001) | 0.135 (0.006) | 0.150 (0.003) | 0.086 (0.082) | 145 ± 76 | 159 ± 75 | 0.108 | 133 ± 63 | 159 ± 76 | 0.007 | 154 ± 76 | 164 ± 66 | 0.152 |
Bilirubin (mg/dL) | 0.319 (< 0.001) | 0.138 (0.005) | 0.202 (< 0.001) | 0.190 (< 0.001) | 5.6 ± 5.2 | 5.6 ± 4.9 | 0.451 | 4.3 ± 5.1 | 5.8 ± 4.9 | < 0.001 | 5.3 ± 4.7 | 7.0 ± 5.9 | 0.012 |
PT (s) | -0.118 (0.017) | -0.038 (0.445) | 0.072 (0.149) | -0.092 (0.061) | 86 ± 16 | 81 ± 18 | 0.032 | 81 ± 20 | 82 ± 18 | 0.795 | 82 ± 18 | 76 ± 17 | 0.006 |
Albumin (g/dL) | -0.282 (< 0.001) | -0.018 (0.717) | -0.017 (0.739) | -0.062 (0.206) | 4.0 ± 0.4 | 3.9 ± 0.4 | 0.404 | 4.1 ± 0.4 | 3.9 ± 0.4 | 0.002 | 4.0 ± 0.4 | 3.7 ± 0.4 | < 0.001 |
Table 3 Multivariate logistic regression analysis for the factors associated with severe acute hepatitis and prolonged cholestasis in acute hepatitis
Variables | OR | 95%CI for OR | P value | |
Lower | Upper | |||
Severe acute hepatitis | ||||
Age (yr) | 1.007 | 0.928 | 1.033 | 0.579 |
Gender, male | 2.569 | 1.477 | 4.469 | 0.001 |
Etiology, toxic | 3.531 | 1.444 | 8.635 | 0.006 |
Albumin (g/dL) | 2.154 | 1.279 | 3.629 | 0.004 |
GWT (mm) | 1.061 | 1.015 | 1.110 | 0.009 |
Prolonged cholestasis in acute hepatitis | ||||
Age (yr) | 0.393 | 0.059 | 2.599 | 0.333 |
Etiology, toxic | 6.848 | 0.960 | 48.859 | 0.055 |
ALT (IU/L) | 1.000 | 1.000 | 1.001 | 0.607 |
Bilirubin (mg/dL) | 1.628 | 1.331 | 1.991 | < 0.001 |
GWT (mm) | 1.172 | 1.024 | 1.342 | 0.021 |
Ascites | 0.484 | 0.119 | 6.039 | 0.869 |
- Citation: Park SJ, Kim JD, Seo YS, Park BJ, Kim MJ, Um SH, Kim CH, Yim HJ, Baik SK, Jung JY, Keum B, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis. World J Gastroenterol 2013; 19(16): 2543-2549
- URL: https://www.wjgnet.com/1007-9327/full/v19/i16/2543.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i16.2543